BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3125 related articles for article (PubMed ID: 2985007)

  • 1. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):913-20. PubMed ID: 3885862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase I study of recombinant human interferon alpha A (Ro 22-8181) in patients with malignant tumors].
    Taguchi T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):456-64. PubMed ID: 4004281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
    Goldberg RM; Ayoob M; Silgals R; Ahlgren JD; Neefe JR
    Cancer Treat Rep; 1985; 69(7-8):813-6. PubMed ID: 4016791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
    Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of various malignancies with recombinant IFN-gamma (S-6810). The IFN-gamma Study Group].
    Takaku F
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):645-52. PubMed ID: 3030197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant leukocyte A interferon in metastasized malignant melanoma].
    Elsässer-Beile U; Schöpf E; Neumann HA; Drews H; Hundhammer K; Balda BR
    Dtsch Med Wochenschr; 1987 Mar; 112(10):373-7. PubMed ID: 3816582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia].
    Ichimaru M; Kamihira S; Moriuchi Y; Kuraishi Y; Usui N; Toki H; Okabe K; Niho Y; Shibuya T; Umei T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
    Sherwin SA; Knost JA; Fein S; Abrams PG; Foon KA; Ochs JJ; Schoenberger C; Maluish AE; Oldham RK
    JAMA; 1982 Nov; 248(19):2461-6. PubMed ID: 6752447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 157.